← Back
$AKBA All transactions

Akebia Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$38K

Shares

27,544

Price

$1

Filed

Feb 4

Insider

Name

Rucci Carolyn M.

Title

SVP, Chief Legal Officer

CIK

0002107264

Roles

Officer

Transaction Details

Transaction Date

2026-02-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

588,378

Footnotes

This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025. | This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2023. | This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024. | This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2025.

Filing Info

Accession No.

0002107264-26-000006

Form Type

4

Issuer CIK

0001517022

Rucci Carolyn M.'s History

Date Ticker Type Value
2026-02-02 AKBA $23K
2026-02-02 AKBA $35K
2026-02-02 AKBA $38K
2026-01-30 AKBA A $0
2026-01-30 AKBA A $0

Other Insiders at AKBA (90d)

Insider Bought Sold Last
Butler John P.
CEO and President
$474K 2026-02-02
Burke Steven Keith
SVP, Chief Medical Officer
$94K 2026-02-02
Vickers Philip J. 2026-04-01
Grund Nicholas
Chief Commercial Officer
$118K 2026-02-02
Ostrowski Erik
SVP, CFO, CBO & Treasurer
$49K 2026-02-02
Malabre Richard C
SVP, Chief Accounting Officer
$69K 2026-02-02
Rucci Carolyn M.
SVP, Chief Legal Officer
$59K 2026-02-02